InvestorsHub Logo

georgejjl

07/04/21 7:04 PM

#319559 RE: Investor2014 #319558

The AVATAR trial was scheduled to be completed last month now projected for mid 2021

https://clinicaltrials.gov/ct2/show/NCT03941444

Actual Study Start Date : May 6, 2019
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021

**************************************************************************

The AEXCELLENCE trial is scheduled to be completed this month

https://clinicaltrials.gov/ct2/show/NCT04304482

Actual Study Start Date : July 1, 2020
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : July 2021

GOD bless,

Steady_T

07/04/21 7:10 PM

#319563 RE: Investor2014 #319558

Neither one of the Rett studies that say recruiting have been updated in a long time. Where they are in the recruiting process is unknown at this time.

raja48185

07/04/21 8:57 PM

#319567 RE: Investor2014 #319558

I agree with your timeline (as the worst case).

But I am hoping that they won't take as much time to do the data tabulation and crunching the second/third time. If they are meeting with the FDA before that, where the recent Rett trial is going to be discussed, they may get some guidance from the FDA that may help speed up the post trial process.

Would be happy if we can get approval by H1 2022 should trial data be good enough.

Going by the general assumption that the drug will be even more effective and telling in Pediatric patients (compared to adolescents), what are the odds that FDA will show some much needed concern and give its blessings for the kids first,(followed by an approval for adolescents based on the other pending trial) should the data be that good? (Knowing that there is already one data set - that recently came out - which shows enough promise).

jimmy667

07/05/21 4:24 AM

#319602 RE: Investor2014 #319558

With $50 million more in the cash position and Missling at the helm next stop is $55. Like it or not. As I tried to get you to wager when AVXL was $13 many months ago I said AVXL will hit $20 before it hits $10 ...haha close it hit $11 but then $33. Next stop $55.
Arrowhead to $300 in three years. Anavex $300 in five years. These are the under development well positioned biotechs. Think Singapore in the 1980s and Vietnam 2022-25.
Dude...you have been here a long time. Anavex is hitting on all eight cylinders get with the program.